Literature DB >> 24164647

On the history of hepatitis C virus cell culture systems.

Volker Lohmann1, Ralf Bartenschlager.   

Abstract

HCV infections are a major global health burden. After the identification of the virus in 1989, insights into viral replication and drug development have long been hampered by the lack of efficient cell culture models. Their establishment was an important prerequisite for the development of selective antivirals. This review describes the initial difficulties to achieve HCV replication in cell culture, finally leading to the establishment of subgenomic replicons and the infectious virus model (HCVcc). The review further summarizes the current state of HCV cell culture systems with respect to available virus isolates, engineered genomes, and cell types allowing efficient HCV propagation. Finally, we comment on how these cell culture models contributed to the development of directly acting antivirals.

Entities:  

Mesh:

Year:  2013        PMID: 24164647     DOI: 10.1021/jm401401n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  40 in total

1.  Characterization of nonprimate hepacivirus and construction of a functional molecular clone.

Authors:  Troels K H Scheel; Amit Kapoor; Eiko Nishiuchi; Kenny V Brock; Yingpu Yu; Linda Andrus; Meigang Gu; Randall W Renshaw; Edward J Dubovi; Sean P McDonough; Gerlinde R Van de Walle; W Ian Lipkin; Thomas J Divers; Bud C Tennant; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

2.  Human norovirus culture in B cells.

Authors:  Melissa K Jones; Katrina R Grau; Veronica Costantini; Abimbola O Kolawole; Miranda de Graaf; Pamela Freiden; Christina L Graves; Marion Koopmans; Shannon M Wallet; Scott A Tibbetts; Stacey Schultz-Cherry; Christiane E Wobus; Jan Vinjé; Stephanie M Karst
Journal:  Nat Protoc       Date:  2015-10-29       Impact factor: 13.491

3.  Hepatitis C virus's next top models?

Authors:  David Paul; Ralf Bartenschlager
Journal:  Nat Microbiol       Date:  2016-01-11       Impact factor: 17.745

4.  Ralf Bartenschlager, Charles Rice, and Michael Sofia are honored with the 2016 Lasker~DeBakey Clinical Medical Research Award.

Authors:  Corinne L Williams
Journal:  J Clin Invest       Date:  2016-09-13       Impact factor: 14.808

5.  Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.

Authors:  Syo Nakajima; Koichi Watashi; Hirofumi Ohashi; Shinji Kamisuki; Jesus Izaguirre-Carbonell; Andrew Tae-Jun Kwon; Harukazu Suzuki; Michiyo Kataoka; Senko Tsukuda; Maiko Okada; Meng Ling Moi; Toshifumi Takeuchi; Minetaro Arita; Ryosuke Suzuki; Hideki Aizaki; Takanobu Kato; Tadaki Suzuki; Hideki Hasegawa; Tomohiko Takasaki; Fumio Sugawara; Takaji Wakita
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

Review 6.  Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees.

Authors:  Babs E Verstrepen; André Boonstra; Gerrit Koopman
Journal:  World J Hepatol       Date:  2015-01-27

7.  Substitutions at NS3 Residue 155, 156, or 168 of Hepatitis C Virus Genotypes 2 to 6 Induce Complex Patterns of Protease Inhibitor Resistance.

Authors:  Sanne B Jensen; Stéphanie B N Serre; Daryl G Humes; Santseharay Ramirez; Yi-Ping Li; Jens Bukh; Judith M Gottwein
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

Review 8.  Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

Authors:  Da-Rong Yang; Hai-Zhen Zhu
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

9.  Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.

Authors:  Christian K Mathiesen; Tanja B Jensen; Jannick Prentoe; Henrik Krarup; Alfredo Nicosia; Mansun Law; Jens Bukh; Judith M Gottwein
Journal:  Virology       Date:  2014-05-24       Impact factor: 3.616

Review 10.  Immune responses to HCV and other hepatitis viruses.

Authors:  Su-Hyung Park; Barbara Rehermann
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.